Share Consolidation and ASX Code Change

Wellnex Life Limited (ASX:WNX) has announced the approval of the consolidation of the Company's issued capital on a fifty for one (50:1) basis. The last day for trading on a pre-consolidation basis was 8 October 2024. Trading in the Company's securities will now take place on a post-consolidation and deferred settlement basis, with the new ASX code 'WNXDA' during this period. Normal trading under ASX code 'WNX' will commence on Monday, 18 October 2024. For more details, refer to the Company's Notice of Extraordinary General Meeting released to the ASX on 28 August 2024.

Executive Commentary on Share Consolidation

The share consolidation marks an important step for Wellnex Life as it streamlines our capital structure and enhances the efficiency of trading in our securities. This move is in line with our commitment to creating value for our shareholders and strengthening our position in the healthcare market segment. We believe that the consolidation will provide a solid foundation for our future growth and expansion plans.

Summary of Share Consolidation and Outlook

Wellnex Life Limited (ASX:WNX) has successfully implemented a share consolidation on a fifty for one (50:1) basis, with the last day for trading on a pre-consolidation basis being 8 October 2024. The Company's securities will now trade on a post-consolidation and deferred settlement basis under the new ASX code 'WNXDA' until normal trading commences on Monday, 18 October 2024 under ASX code 'WNX'. The consolidation is expected to streamline the company's capital structure and trading efficiency. Wellnex Life remains focused on its commitment to creating value for shareholders and aims to strengthen its position in the healthcare market segment, leveraging the consolidation as a foundation for future growth and expansion plans.